Evaluación clínica, pronóstico y terapéutica del linfoma de Hodgkin del adulto

Pavlovsky, Santiago; Pavlovsky, Astrid.
Salud(i)ciencia (Impresa) ; 17(8): 755-759, sept. 2010.
Artículo en Español | LILACS | ID: lil-567642

Documentos relacionados

  1. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
  2. Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a real-world setting.
  3. NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
  4. Late relapses in Hodgkin lymphoma - should we search for the needle in the haystack?
  5. Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach.
  6. Immunotherapy in Hodgkin Lymphoma: The Road Ahead.
  7. Barriers to long-term follow-up in pediatric Hodgkin lymphoma survivors.
  8. Decision-Making among Experts in Advanced Hodgkin Lymphoma.
  9. Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years.
  10. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.